Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Oncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic oncolytic agents that would generate durable and multifaceted anti-tumor immune responses to disrupt the tumors. He...

Full description

Bibliographic Details
Main Authors: Yong Luo, Chaolong Lin, Yidi Zou, Fei Ju, Wenfeng Ren, Yanhua Lin, Yale Wang, Xiaoxuan Huang, Huiling Liu, Zeng Yu, Pingguo Liu, Guowei Tan, Quan Yuan, Jun Zhang, Chenghao Huang, Ningshao Xia
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
oncolytic virus
tumor-targeting
therapeutic antibodies
cancer vaccine
anti-tumor effect
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1726168

Internet

http://dx.doi.org/10.1080/2162402X.2020.1726168

Similar Items